A novel germline MLH1 mutation causing lynch syndrome in patients from the Republic of Macedonia

Croatian Medical Journal

Volumn 53, Issue 5, 2012, Pages 496-501

  Hiljadnikova Bajro, Marija ^a   Josifovski, Toni ^b,c   Panovski, Milco ^b   Dimovski, Aleksandar J ^a  

^a SS Cyril and Methodius University Faculty of Pharmacy   (Macedonia)

^b SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^c Clinical Hospital Sistina   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GERM LINE; HAPLOTYPE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LETTER; MACEDONIA (REPUBLIC); MALE; MISMATCH REPAIR; MLH1 GENE; MSH2 GENE; NONSENSE MUTATION; PEDIGREE; POINT MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; FEMALE; FOUNDER EFFECT; GERM-LINE MUTATION; HAPLOTYPES; HUMANS; MACEDONIA (REPUBLIC); MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION, MISSENSE; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; PEDIGREE; POINT MUTATION; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 84871883813     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.496     Document Type: Letter

References (30)

1. L ynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919-32.
2. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol. 2003;21:1174-9.
3. R owley PT. Inherited susceptibility to colorectal cancer. Annu Rev Med. 2005;56:539-54.
4. L each FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215-25.
5. N icolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80.
6. N ystrom-Lahti M, Parsons R, Sistonen P, Pylkkanen L, Aaltonen LA, Leach FS, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet. 1994;55:659-65.
7. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994;263:1625-9.
8. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994;368:258-61.
9. Kohlmann W, Gruber SB. Lynch syndrome. In: Pagon RA, Bird TD, Dolan CR, et al., editors. GeneReviews™. Seattle (WA): University of Washington, Seattle; 1993-2004. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1211. Accessed: October 1, 2012.
10. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75:1027-38.
11. ambrook J, Fritsch EF, Maniatis T. Molecular cloning-a laboratory manual, 2nd ed. New York (NY): Cold Spring Habour Laboratory Press; 1989.
12. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-6.
13. U mar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261-8.
14. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-57.
15. S chouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.
16. Perez-Carbonell L, Alenda C, Paya A, Castillejo A, Barberá VM, Guillen C, et al. Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome. J Mol Diagn. 2010;12:498-504.
17. Yap HL, Chieng WS, Lim JR, Lim RS, Soo R, Guo J, et al. Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore. Fam Cancer. 2009;8:85-94.
18. L ipkin SM, Rozek LS, Rennert G, Yang W, Chen PC, Hacia J, et al. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat Genet. 2004;36:694-9.
19. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:42-65.
20. S hia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part 1: The utility of immunohistochemistry. J Mol Diagn. 2008;10:293-300.
21. Parsons MT, Buchanan DD, Thompson B, Young JP, Spurdle AB. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification. J Med Genet. 2012;49:151-7.
22. Bouzourene H, Hutter P, Losi L, Martin P, Benhattar J. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Fam Cancer. 2010;9:167-72.
23. Bellizzi AM, Frankel WL. Colorectal cancer due to deficiency in DNA mismatch repair function: a review. Adv Anat Pathol. 2009;16:405-17.
24. G ausachs M, Mur P, Corral J, Pineda M, González S, Benito L, et al. MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study. Eur J Hum Genet. 2012;20:762-8.
25. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820-3.
26. U niSTS database. Available from: http://www.ncbi.nlm.nih.gov/unists. Accessed: October 1, 2012.
27. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLO BOCAN 2008 version 1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer 2010. Available from http://globocaniarc.fr. Accessed: October 12, 2012.
28. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
29. The Human Gene Mutation Database. Available from: http://www.hgmd.cf.ac.uk/ac/index.php. Accessed: October 1, 2012.
30. Kurzawski G, Suchy J, Lener M, Klujszo-Grabowska E, Kladny J, Safranow K, et al. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006;69:40-7.